ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04110	Cell cycle	3/7	145/7206	0.000263263530372
ko05216	Thyroid cancer	2/7	34/7206	0.000447143993811
ko05224	Breast cancer	3/7	174/7206	0.000450954443229
ko04310	Wnt signaling pathway	3/7	181/7206	0.000506440062143
ko05219	Bladder cancer	2/7	48/7206	0.000893253431613
ko05213	Endometrial cancer	2/7	62/7206	0.00148777197694
ko05205	Proteoglycans in cancer	3/7	271/7206	0.00164521159792
ko05223	Non-small cell lung cancer	2/7	66/7206	0.00168448009663
ko05217	Basal cell carcinoma	2/7	68/7206	0.00178726570971
ko05166	HTLV-I infection	3/7	292/7206	0.00204137080242
ko04115	p53 signaling pathway	2/7	74/7206	0.00211324678196
ko05214	Glioma	2/7	79/7206	0.00240496597598
ko05212	Pancreatic cancer	2/7	83/7206	0.00265138202818
ko05220	Chronic myeloid leukemia	2/7	85/7206	0.00277891383496
ko05218	Melanoma	2/7	85/7206	0.00277891383496
ko05210	Colorectal cancer	2/7	86/7206	0.00284375701495
ko05222	Small cell lung cancer	2/7	89/7206	0.00304258311064
ko05215	Prostate cancer	2/7	111/7206	0.0046950886928
ko05162	Measles	2/7	120/7206	0.00546812015697
ko01522	Endocrine resistance	2/7	124/7206	0.00582945927577
ko04919	Thyroid hormone signaling pathway	2/7	143/7206	0.00769279492704
ko05200	Pathways in cancer	3/7	492/7206	0.0089973685263
ko05161	Hepatitis B	2/7	173/7206	0.0111163419582
ko05206	MicroRNAs in cancer	2/7	177/7206	0.0116161716205
ko04218	Cellular senescence	2/7	177/7206	0.0116161716205
ko04390	Hippo signaling pathway	2/7	188/7206	0.013042101881
ko05202	Transcriptional misregulation in cancer	2/7	188/7206	0.013042101881
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/7	191/7206	0.0134439540285
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	1/7	26/7206	0.0249952772733
ko05203	Viral carcinogenesis	2/7	277/7206	0.0272059366428
ko03410	Base excision repair	1/7	38/7206	0.0363497055298
ko04216	Ferroptosis	1/7	44/7206	0.0419842874906